ConductScience.org, home

Trial · NCT01154296

HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.

NCT01154296, Not applicable, Completed, Columbia University; results first posted 2014-09-29

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S. Trials, record NCT01154296. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01154296

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
NCT number
NCT01154296
Status
Completed
Phases
Not applicable
Enrollment
5,012 participants, actual
Lead sponsor
Columbia University
Conditions
HIV/AIDS, Sexually Transmitted Infections
Interventions
RESPECT-2 Counseling
First posted
2010-06-30
Last updated
2014-09-29
Results first posted
2014-09-29

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySTI Incidence6 months post randomizationComposite STI incidence (Yes/No) at 6-month follow-up in which a person is considered positive for STIs if they are positive on any tested STI.
SecondarySexual Risk Behavior -- # of Sex Acts6 months post randomizationSelf-reported continuous variables to determine number of (vaginal and/or anal) sex acts.
SecondarySexual Risk Behavior -- # of Unprotected Sex Acts6 months post randomizationSelf-reported continuous variables to determine number of unprotected (vaginal and/or anal) sex acts
SecondarySexual Risk Behavior -- # of Partners6 months post randomizationSelf-reported continuous variables to determine number of partners with whom the participant had (vaginal and/or anal) sex.
SecondarySexual Risk Behavior -- # of Unprotected Partners6 months post randomizationSelf-reported continuous variables to determine number of partners with whom the participant had unprotected (vaginal and/or anal) sex.
SecondarySexual Risk Behavior -- # of Sex Acts With Substance Use6 months post randomizationSelf-reported continuous variables to determine number of (vaginal and/or anal) sex acts in which the participant reported using substances before the sex act.

Outcomes6

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYSTI Incidence6 months post randomizationparticipantsNUMBER
SECONDARYSexual Risk Behavior -- # of Sex Acts6 months post randomizationsex actsLEAST_SQUARES_MEAN
SECONDARYSexual Risk Behavior -- # of Unprotected Sex Acts6 months post randomizationunprotected sex actsLEAST_SQUARES_MEAN
SECONDARYSexual Risk Behavior -- # of Partners6 months post randomizationpartnersLEAST_SQUARES_MEAN
SECONDARYSexual Risk Behavior -- # of Unprotected Partners6 months post randomizationunprotected partnersLEAST_SQUARES_MEAN
SECONDARYSexual Risk Behavior -- # of Sex Acts With Substance Use6 months post randomizationsex acts with substance useNUMBER

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
STI IncidenceRapid HIV Testing w/ Counseling (Group 1)250participants
STI IncidenceRapid HIV Testing & Information Only (Group 2)226participants
Sexual Risk Behavior -- # of Sex ActsRapid HIV Testing w/ Counseling (Group 1)28.6Standard Error 1.1312sex acts
Sexual Risk Behavior -- # of Sex ActsRapid HIV Testing & Information Only (Group 2)29.1Standard Error 1.1553sex acts
Sexual Risk Behavior -- # of Unprotected Sex ActsRapid HIV Testing w/ Counseling (Group 1)17.4Standard Error 0.9791unprotected sex acts
Sexual Risk Behavior -- # of Unprotected Sex ActsRapid HIV Testing & Information Only (Group 2)18.3Standard Error 1.0381unprotected sex acts
Sexual Risk Behavior -- # of PartnersRapid HIV Testing w/ Counseling (Group 1)2.7Standard Error 0.07454partners
Sexual Risk Behavior -- # of PartnersRapid HIV Testing & Information Only (Group 2)3.0Standard Error 0.08386partners
Sexual Risk Behavior -- # of Unprotected PartnersRapid HIV Testing w/ Counseling (Group 1)1.1Standard Error 0.03749unprotected partners
Sexual Risk Behavior -- # of Unprotected PartnersRapid HIV Testing & Information Only (Group 2)1.1Standard Error 0.03845unprotected partners

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Randomization and InterventionSTARTEDRapid HIV Testing w/ Counseling (Group 1)2,505
Randomization and InterventionSTARTEDRapid HIV Testing & Information Only (Group 2)2,507
Randomization and InterventionCOMPLETEDRapid HIV Testing w/ Counseling (Group 1)2,500
Randomization and InterventionCOMPLETEDRapid HIV Testing & Information Only (Group 2)2,505
Randomization and InterventionNOT COMPLETEDRapid HIV Testing w/ Counseling (Group 1)5
Randomization and InterventionNOT COMPLETEDRapid HIV Testing & Information Only (Group 2)2
6-month Follow-upSTARTEDRapid HIV Testing w/ Counseling (Group 1)2,505
6-month Follow-upSTARTEDRapid HIV Testing & Information Only (Group 2)2,507
6-month Follow-upCOMPLETEDRapid HIV Testing w/ Counseling (Group 1)2,177
6-month Follow-upCOMPLETEDRapid HIV Testing & Information Only (Group 2)2,179

Adverse events10

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousDeath, cause unknownGeneral disordersRapid HIV Testing w/ Counseling (Group 1)12,5051
seriousDeath, cause unknownGeneral disordersRapid HIV Testing & Information Only (Group 2)02,5070
seriousvictim of homicide, secondary to robberyGeneral disordersRapid HIV Testing w/ Counseling (Group 1)12,5051
seriousvictim of homicide, secondary to robberyGeneral disordersRapid HIV Testing & Information Only (Group 2)02,5070
seriousCancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)Rapid HIV Testing w/ Counseling (Group 1)12,5051
seriousCancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)Rapid HIV Testing & Information Only (Group 2)02,5070
seriousHeart failureCardiac disordersRapid HIV Testing w/ Counseling (Group 1)02,5050
seriousHeart failureCardiac disordersRapid HIV Testing & Information Only (Group 2)12,5071
seriousMetastatic colon cancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)Rapid HIV Testing w/ Counseling (Group 1)02,5050
seriousMetastatic colon cancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)Rapid HIV Testing & Information Only (Group 2)12,5071

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityRapid HIV Testing w/ Counseling (Group 1)
Total, all-cause mortalityRapid HIV Testing & Information Only (Group 2)
Total, other adverse eventsRapid HIV Testing w/ Counseling (Group 1)02,505
Total, other adverse eventsRapid HIV Testing & Information Only (Group 2)02,507
Total, serious adverse eventsRapid HIV Testing w/ Counseling (Group 1)32,505
Total, serious adverse eventsRapid HIV Testing & Information Only (Group 2)22,507

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
24150466RESULTPubMed
26071390DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
RC2DA028973HIV Testing and Counseling in STD Clinics: an Adaptation of CTN 0032FEASTER, DANIEL JUNIVERSITY OF MIAMI SCHOOL OF MEDICINENATIONAL INSTITUTE ON DRUG ABUSE2009 to 2010

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Rapid HIV Testing w/ Counseling (Group 1) vs Rapid HIV Testing & Information Only (Group 2): STI IncidenceTrial comparisons
Rapid HIV Testing w/ Counseling (Group 1) vs Rapid HIV Testing & Information Only (Group 2): serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01154296

GET https://conductscience.org/api/trials/v1/NCT01154296/registered